Awarded contractNeg Wo CallSuppliesSpain
Suministro del principio activo denominado "Sacituzumab Govitecan 200 MG VIAL PERFIV".
1 supplier awarded•1 lot awarded•€185,592 awarded
Buyer: Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín / Las Palmas de Gran Canaria, Spain
Published Aug 12, 2024Awarded Aug 05, 2024
Various medicinal products
Awarded value
€185.6K
Estimated value
€185.6K
Awarded at 100% of estimated value
Award date
Aug 05, 2024
Winners
1
Lots awarded
1
Winners
GILEAD SCIENCES, S.L.
1 lotMADRID, ESP
€185,592 This contract
35 award notices•38 awarded lots•€35.44M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0000 | GILEAD SCIENCES, S.L. | €185,592 | Various medicinal products (33690000) |